• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用电子健康记录实时预测 COVID-19 相关死亡率。

Real-time prediction of COVID-19 related mortality using electronic health records.

机构信息

F. Hoffmann-La Roche Ltd, Basel, Switzerland.

Max Planck Institute for Intelligent Systems, Tübingen, Germany.

出版信息

Nat Commun. 2021 Feb 16;12(1):1058. doi: 10.1038/s41467-020-20816-7.

DOI:10.1038/s41467-020-20816-7
PMID:33594046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7886884/
Abstract

Coronavirus disease 2019 (COVID-19) is a respiratory disease with rapid human-to-human transmission caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Due to the exponential growth of infections, identifying patients with the highest mortality risk early is critical to enable effective intervention and prioritisation of care. Here, we present the COVID-19 early warning system (CovEWS), a risk scoring system for assessing COVID-19 related mortality risk that we developed using data amounting to a total of over 2863 years of observation time from a cohort of 66 430 patients seen at over 69 healthcare institutions. On an external cohort of 5005 patients, CovEWS predicts mortality from 78.8% (95% confidence interval [CI]: 76.0, 84.7%) to 69.4% (95% CI: 57.6, 75.2%) specificity at sensitivities greater than 95% between, respectively, 1 and 192 h prior to mortality events. CovEWS could enable earlier intervention, and may therefore help in preventing or mitigating COVID-19 related mortality.

摘要

2019 年冠状病毒病(COVID-19)是一种由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的呼吸道疾病,具有快速的人际传播能力。由于感染呈指数级增长,早期识别死亡率最高的患者对于进行有效的干预和优先提供护理至关重要。在这里,我们提出了 COVID-19 早期预警系统(CovEWS),这是一种评估 COVID-19 相关死亡率风险的风险评分系统,我们使用来自 66430 名患者的超过 2863 年的观察时间的数据开发了该系统,这些患者来自 69 家以上的医疗机构。在一个由 5005 名患者组成的外部队列中,CovEWS 在死亡率发生前 1 至 192 小时之间的灵敏度大于 95%时,预测死亡率的特异性分别为 78.8%(95%置信区间[CI]:76.0,84.7%)至 69.4%(95% CI:57.6,75.2%)。CovEWS 可以实现更早的干预,因此可能有助于预防或减轻 COVID-19 相关的死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a455/7886884/472a54544e19/41467_2020_20816_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a455/7886884/5531c37a6896/41467_2020_20816_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a455/7886884/9d635255234c/41467_2020_20816_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a455/7886884/472a54544e19/41467_2020_20816_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a455/7886884/5531c37a6896/41467_2020_20816_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a455/7886884/9d635255234c/41467_2020_20816_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a455/7886884/472a54544e19/41467_2020_20816_Fig3_HTML.jpg

相似文献

1
Real-time prediction of COVID-19 related mortality using electronic health records.利用电子健康记录实时预测 COVID-19 相关死亡率。
Nat Commun. 2021 Feb 16;12(1):1058. doi: 10.1038/s41467-020-20816-7.
2
Effectiveness of the rapid emergency medicine score and the rapid acute physiology score in prognosticating mortality in patients presenting to the emergency department with COVID-19 symptoms.快速急诊医学评分和快速急性生理学评分在预测因 COVID-19 症状就诊于急诊科的患者死亡率方面的有效性。
Am J Emerg Med. 2021 Nov;49:259-264. doi: 10.1016/j.ajem.2021.06.020. Epub 2021 Jun 10.
3
Evaluation of the Risk Prediction Tools for Patients With Coronavirus Disease 2019 in Wuhan, China: A Single-Centered, Retrospective, Observational Study.中国武汉 2019 年冠状病毒病患者风险预测工具的评估:一项单中心、回顾性、观察性研究。
Crit Care Med. 2020 Nov;48(11):e1004-e1011. doi: 10.1097/CCM.0000000000004549.
4
National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 - a prospective cohort study.入院时的国家早期预警评分 2 (NEWS2)可预测新冠病毒疾病的严重程度和住院死亡率-一项前瞻性队列研究。
Scand J Trauma Resusc Emerg Med. 2020 Jul 13;28(1):66. doi: 10.1186/s13049-020-00764-3.
5
The performance of the National Early Warning Score and National Early Warning Score 2 in hospitalised patients infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染住院患者的国家早期预警评分和国家早期预警评分 2 的性能。
Resuscitation. 2021 Feb;159:150-157. doi: 10.1016/j.resuscitation.2020.10.039. Epub 2020 Nov 8.
6
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.挪威 2019 年冠状病毒病(NO COVID-19)实用开放性标签研究,评估硫酸羟氯喹在 2019 年冠状病毒病中度重症住院患者中的早期使用:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.
7
Comparing Rapid Scoring Systems in Mortality Prediction of Critically Ill Patients With Novel Coronavirus Disease.比较新型冠状病毒疾病危重症患者死亡率预测的快速评分系统。
Acad Emerg Med. 2020 Jun;27(6):461-468. doi: 10.1111/acem.13992. Epub 2020 May 21.
8
Universal screening for SARS-CoV-2 infection: a rapid review.SARS-CoV-2 感染的普遍筛查:快速综述。
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718.
9
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
10
Multisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities.新冠肺炎危重症患者的多系统结局和死亡率预测因素:人口统计学和疾病严重程度比合并症或治疗方式更重要。
J Trauma Acute Care Surg. 2021 May 1;90(5):880-890. doi: 10.1097/TA.0000000000003085.

引用本文的文献

1
Medical laboratory data-based models: opportunities, obstacles, and solutions.基于医学实验室数据的模型:机遇、障碍与解决方案。
J Transl Med. 2025 Jul 24;23(1):823. doi: 10.1186/s12967-025-06802-x.
2
Profiling short-term longitudinal severity progression and associated genes in COVID-19 patients using EHR and single-cell analysis.利用电子健康记录和单细胞分析对新冠病毒患者的短期纵向严重程度进展及相关基因进行分析。
Sci Rep. 2025 Jul 1;15(1):21098. doi: 10.1038/s41598-025-07793-x.
3
Disease progression associated cytokines in COVID-19 patients with deteriorating and recovering health conditions.

本文引用的文献

1
Early triage of critically ill COVID-19 patients using deep learning.使用深度学习对危重症 COVID-19 患者进行早期分诊。
Nat Commun. 2020 Jul 15;11(1):3543. doi: 10.1038/s41467-020-17280-8.
2
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.纽约市 5279 例 2019 年冠状病毒病患者住院和重症的相关因素:前瞻性队列研究。
BMJ. 2020 May 22;369:m1966. doi: 10.1136/bmj.m1966.
3
Early warning scores for detecting deterioration in adult hospital patients: systematic review and critical appraisal of methodology.
与 COVID-19 患者病情恶化和康复相关的疾病进展相关细胞因子。
Sci Rep. 2024 Oct 21;14(1):24712. doi: 10.1038/s41598-024-75924-x.
4
In-hospital real-time prediction of COVID-19 severity regardless of disease phase using electronic health records.使用电子健康记录对COVID-19严重程度进行院内实时预测,无论疾病处于何阶段。
PLoS One. 2024 Jan 25;19(1):e0294362. doi: 10.1371/journal.pone.0294362. eCollection 2024.
5
Utilizing machine learning for survival analysis to identify risk factors for COVID-19 intensive care unit admission: A retrospective cohort study from the United Arab Emirates.利用机器学习进行生存分析,以确定 COVID-19 重症监护病房收治的危险因素:来自阿拉伯联合酋长国的回顾性队列研究。
PLoS One. 2024 Jan 11;19(1):e0291373. doi: 10.1371/journal.pone.0291373. eCollection 2024.
6
Developing deep learning-based strategies to predict the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease from electronic health records.基于深度学习制定策略,通过电子健康记录预测非酒精性脂肪性肝病患者的肝细胞癌风险。
medRxiv. 2023 Nov 17:2023.11.17.23298691. doi: 10.1101/2023.11.17.23298691.
7
Use of Natural Language Processing of Patient-Initiated Electronic Health Record Messages to Identify Patients With COVID-19 Infection.利用自然语言处理技术对患者发起的电子健康记录消息进行分析,以识别 COVID-19 感染患者。
JAMA Netw Open. 2023 Jul 3;6(7):e2322299. doi: 10.1001/jamanetworkopen.2023.22299.
8
Patient and researcher stakeholder preferences for use of electronic health record data: a qualitative study to guide the design and development of a platform to honor patient preferences.患者和研究人员利益相关者对使用电子健康记录数据的偏好:一项定性研究,以指导一个尊重患者偏好的平台的设计和开发。
J Am Med Inform Assoc. 2023 May 4;30(6):1137-49. doi: 10.1093/jamia/ocad058.
9
Conditional generation of medical time series for extrapolation to underrepresented populations.用于外推至代表性不足人群的医学时间序列的条件生成。
PLOS Digit Health. 2022 Jul 19;1(7):e0000074. doi: 10.1371/journal.pdig.0000074. eCollection 2022 Jul.
10
Development and validation of a dynamic 48-hour in-hospital mortality risk stratification for COVID-19 in a UK teaching hospital: a retrospective cohort study.在英国教学医院中开发和验证一种针对 COVID-19 的动态 48 小时院内死亡风险分层模型:一项回顾性队列研究。
BMJ Open. 2022 Sep 5;12(9):e060026. doi: 10.1136/bmjopen-2021-060026.
成人住院患者病情恶化预警评分的研究:系统评价与方法学的严格评价。
BMJ. 2020 May 20;369:m1501. doi: 10.1136/bmj.m1501.
4
Treatment in Disproportionately Minority Hospitals Is Associated With Increased Risk of Mortality in Sepsis: A National Analysis.在少数民族比例过高的医院接受治疗与脓毒症患者的死亡率升高相关:一项全国性分析。
Crit Care Med. 2020 Jul;48(7):962-967. doi: 10.1097/CCM.0000000000004375.
5
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.危重症和死亡 COVID-19 病例的风险因素:系统文献回顾和荟萃分析。
J Infect. 2020 Aug;81(2):e16-e25. doi: 10.1016/j.jinf.2020.04.021. Epub 2020 Apr 23.
6
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
7
Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures.SARS-CoV、MERS-CoV 和 SARS-CoV-2(2019-nCoV)的实验室检测:现状、挑战和对策。
Rev Med Virol. 2020 May;30(3):e2106. doi: 10.1002/rmv.2106. Epub 2020 Apr 17.
8
Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score.COVID-19 肺炎患者进展风险预测:CALL 评分。
Clin Infect Dis. 2020 Sep 12;71(6):1393-1399. doi: 10.1093/cid/ciaa414.
9
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal.COVID-19 诊断和预后预测模型:系统评价和批判性评估。
BMJ. 2020 Apr 7;369:m1328. doi: 10.1136/bmj.m1328.
10
Developing Covid-19 Vaccines at Pandemic Speed.以大流行速度研发新冠疫苗。
N Engl J Med. 2020 May 21;382(21):1969-1973. doi: 10.1056/NEJMp2005630. Epub 2020 Mar 30.